These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4349107)

  • 21. Gaviscon for gastro-oesophageal reflux in infants: a poorly effective treatment?
    Cresi F; Savino F; Marinaccio C; Silvestro L
    Arch Dis Child; 2006 Jan; 91(1):93. PubMed ID: 16371388
    [No Abstract]   [Full Text] [Related]  

  • 22. In-vivo anti-reflux and raft properties of alginates.
    Lambert JR; Korman MG; Nicholson L; Chan JG
    Aliment Pharmacol Ther; 1990 Dec; 4(6):615-22. PubMed ID: 2129648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gaviscon].
    Ménégol-Couque B; Brard M
    Soins; 1985 Jun; (455):I-II. PubMed ID: 2994235
    [No Abstract]   [Full Text] [Related]  

  • 24. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
    Corvaglia L; Aceti A; Mariani E; De Giorgi M; Capretti MG; Faldella G
    Aliment Pharmacol Ther; 2011 Feb; 33(4):466-70. PubMed ID: 21158879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastro-oesophageal pH measurements during reflux induced by provocative tests.
    Baldi F; Longanesi A; Ferrarini F; Ragazzini M; Michieletti G
    Br J Clin Pract Suppl; 1989 Feb; 66():10-4; discussion 35-6. PubMed ID: 2511916
    [No Abstract]   [Full Text] [Related]  

  • 26. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Arch Dis Child; 1992 May; 67(5):618-21. PubMed ID: 1599300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicentric, randomized clinical trial of Gaviscon in reflux esophagitis.
    McHardy G
    South Med J; 1978 Jan; 71 Suppl 1():16-21. PubMed ID: 204058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension.
    Washington N; Greaves JL; Iftikhar SY
    Aliment Pharmacol Ther; 1992 Oct; 6(5):579-88. PubMed ID: 1420749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Can acid pocket-targeting alginate-antacid (Gaviscon Double Action) relieve upper gastrointestinal symptoms in gastro-oesophageal reflux disease?].
    Kim SE; Park MI
    Korean J Gastroenterol; 2014 Jun; 63(6):386-8. PubMed ID: 25097964
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial.
    Eriksen CA; Cheadle WG; Cranford CA; Cuschieri A
    Ann Chir Gynaecol; 1988; 77(4):133-7. PubMed ID: 2855391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gaviscon in reflux symptoms. Results of a drug monitoring study].
    Hutt HJ; Tauber O; Flach D
    Fortschr Med; 1990 Oct; 108(31):598-600. PubMed ID: 2258131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH.
    Del Buono R; Wenzl TG; Ball G; Keady S; Thomson M
    Arch Dis Child; 2005 May; 90(5):460-3. PubMed ID: 15851425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
    Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
    Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alginate raft: a scintigraphic evaluation.
    McKay AP; Wraight EP; Hunter JO
    Br J Clin Pract Suppl; 1989 Feb; 66():20-4; discussion 35-6. PubMed ID: 2511919
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of reflux oesophagitis.
    Hamill JJ
    Practitioner; 1983 Apr; 227(1378):637-9. PubMed ID: 6304672
    [No Abstract]   [Full Text] [Related]  

  • 36. Pyrogastrone for oesophagitis.
    Drug Ther Bull; 1979 Aug; 17(16):63-4. PubMed ID: 228924
    [No Abstract]   [Full Text] [Related]  

  • 37. Reflux esophagitis. A comparison of old and new medical management.
    Grossmann AE; Klotz AP; Rhodes JB; Korb T
    J Kans Med Soc; 1973 Nov; 74(11):423-4. PubMed ID: 4357380
    [No Abstract]   [Full Text] [Related]  

  • 38. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of a aluminum hydroxide suspension in gastroesophageal reflux of infants].
    Olives JP; Rives JJ; Ghisolfi J
    Med Chir Dig; 1980; 9(2):163-5. PubMed ID: 7401729
    [No Abstract]   [Full Text] [Related]  

  • 40. [Multicenter study of sodium alginate in the treatment of regurgitation in infants].
    Le Luyer B; Mougenot JF; Mashako L; Chapoy P; Olives JP; Morali A; Chevallier B; Ginies JL; Dupont C; Dagorne M
    Ann Pediatr (Paris); 1992 Dec; 39(10):635-40. PubMed ID: 1485782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.